Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Chemotherapy in the Management of Adults With Newly Diagnosed Metastatic Brain Tumors

被引：22

作者：

Sherman, Jonathan H. ^{[1
]}

Lo, Simon S. ^{[2
]}

Harrod, Tom ^{[3
]}

Hdeib, Alia ^{[4
]}

Li, Yiping ^{[5
]}

Ryken, Timothy ^{[6
]}

Olson, Jeffrey J. ^{[7
]}

机构：

[1] George Washington Univ, Sch Med & Hlth Sci, Dept Neurosurg, Washington, DC 20052 USA

[2] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA USA

[3] George Washington Univ, Sch Med & Hlth Sci, Himmelfarb Hlth Sci Lib, Washington, DC 20052 USA

[4] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA

[5] Univ Wisconsin, Dept Neurosurg, Madison, WI USA

[6] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA

[7] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA

来源：

NEUROSURGERY | 2019年 / 84卷 / 03期

关键词：

Brain metastases; Cerebral metastases; Chemotherapy; Practice guideline; Stereotactic radiosurgery; Systematic review; Whole brain radiation therapy; CELL LUNG-CANCER; PHASE-III TRIAL; RADIATION-THERAPY; STEREOTACTIC RADIOSURGERY; CONCURRENT-TEMOZOLOMIDE; IRRADIATION; RADIOTHERAPY; CONCOMITANT; TOPOTECAN; BREAST;

D O I：

10.1093/neuros/nyy544

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

QUESTION 1 Should patients with brain metastases receive chemotherapy in addition to whole brain radiotherapy (WBRT) for the treatment of their brain metastases? TARGET POPULATION This recommendation applies to adult patients with newly diagnosed brain metastases amenable to both chemotherapy and radiation treatment. RECOMMENDATIONS Level 1: Routine use of chemotherapy following WBRT for brain metastases is not recommended. Level 3: Routine use of WBRT plus temozolomide is recommended as a treatment for patients with triple negative breast cancer. QUESTION 2 Should patients with brain metastases receive chemotherapy in addition to stereotactic radiosurgery (SRS) for the treatment of their brain metastases? RECOMMENDATIONS Level 1: Routine use of chemotherapy following SRS is not recommended. Level 2: SRS is recommended in combination with chemotherapy to improve overall survival and progression free survival in lung adenocarcinoma patients. QUESTION 3 Should patients with brain metastases receive chemotherapy alone? RECOMMENDATION Level 1: Routine use of cytotoxic chemotherapy alone for brain metastases is not recommended as it has not been shown to increase overall survival. Please see the full-text version of this guideline (https://www.cns.org/guidelines/guidelines-treatment-adults-metastatic-brain-tumors/chapter_5) for the target population of each recommendation.

引用

页码：E175 / E177

页数：3

共 21 条

[11] Liu M, 2010, CHIN GER J CLIN ONCO, V9, P17
[12] Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: a meta-analysis
Liu, Ruifeng
Wang, Xiaohu
Ma, Bin
Yang, Kehu
Zhang, Qiuning
Tian, Jinhui
[J]. ANTI-CANCER DRUGS, 2010, 21 (01) : 120 - 128
[13] Whole Brain Radiotherapy Plus Chemotherapy in the Treatment of Brain Metastases from Lung Cancer: A Metaanalysis of 19 Randomized Controlled Trails
Liu, Wen-Jing
Zeng, Xian-Tao
Qin, Hai-Feng
Gao, Hong-Jun
Bi, Wei-Jing
Liu, Xiao-Qing
[J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (07) : 3253 - 3258
[14] The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
Mehta, Minesh P.
Paleologos, Nina A.
Mikkelsen, Tom
Robinson, Paula D.
Ammirati, Mario
Andrews, David W.
Asher, Anthony L.
Burri, Stuart H.
Cobbs, Charles S.
Gaspar, Laurie E.
Kondziolka, Douglas
Linskey, Mark E.
Loeffler, Jay S.
McDermott, Michael
Olson, Jeffrey J.
Patchell, Roy A.
Ryken, Timothy C.
Kalkanis, Steven N.
[J]. JOURNAL OF NEURO-ONCOLOGY, 2010, 96 (01) : 71 - 83
[15] A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of maliqnant melanoma
Mornex, F
Thomas, L
Mohr, P
Hauschild, A
Delaunay, MM
Lesimple, T
Tilgen, W
Bui, BN
Guillot, B
Ulrich, J
Bourdin, S
Mousseau, M
Cupissol, D
Bonneterre, ME
de Gislain, C
Bensadoun, RJ
Clavel, M
[J]. MELANOMA RESEARCH, 2003, 13 (01) : 97 - 103
[16] Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases - Survey by outcome research network for evaluation of treatment results in oncology
Moscetti, Luca
Nelli, Fabrizio
Felici, Alessandra
Rinaldi, Massimo
De Santis, Stefano
D'Auria, Giuliana
Mansueto, Giovanni
Tonini, Giuseppe
Sperduti, Isabella
Pollera, Francesco C.
[J]. CANCER, 2007, 109 (02) : 274 - 281
[17] A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer
Neuhaus, T.
Ko, Y.
Muller, R. P.
Grabenbauer, G. G.
Hedde, J. P.
Schueller, H.
Kocher, M.
Stier, S.
Fietkau, R.
[J]. BRITISH JOURNAL OF CANCER, 2009, 100 (02) : 291 - 297
[18] Treatment of brain metastases of small-cell lung cancer: Comparing teniposide and teniposide with whole-brain radiotherapy - A phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group
Postmus, PE
Haaxma-Reiche, H
Smit, EF
Groen, HJM
Karnicka, H
Lewinski, T
van Meerbeeck, J
Clerico, M
Gregor, A
Curran, D
Sahmoud, T
Kirkpatrick, A
Giaccone, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3400 - 3408
[19] Recursive Partitioning Analysis Groups II-III Brain Metastases of Non-small Cell Lung Cancer A Phase II Randomized Study Comparing Two Concurrent Chemoradiotherapy Regimens
Quantin, Xavier
Bozonnat, Marie Cecile
Pujol, Jean-Louis
[J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 846 - 851
[20] Brain Metastases From Melanoma Is There a Role for Concurrent Temozolomide in Addition to Whole Brain Radiation Therapy?
Schild, Steven E.
Behl, Deepti
Markovic, Svetomir N.
Brown, Paul D.
Sande, Jonathan R.
Deming, Richard L.
Rowland, Kendrith M., Jr.
Bearden, James D.
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 633 - 636

← 1 2 3 →